$SRPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sarepta Therapeutics, Inc.. Get notifications about new insider transactions in Sarepta Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 2,500 | 34,275 | 22,793 | 20.3 K to 22.8 K (+12.32 %) |
| Jun 28 2017 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Option Exercise | A | 34.65 | 3,300,000 | 114,345,000 | 3,300,000 | |
| Jun 28 2017 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Grant | A | 0.00 | 335,000 | 0 | 335,000 | 0 to 335 K |
| Jun 08 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | A | 34.64 | 40,000 | 1,385,600 | 40,000 | |
| Apr 24 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President & CEO | Payment of Exercise | F | 32.54 | 4,349 | 141,516 | 66,820 | 71.2 K to 66.8 K (-6.11 %) |
| Mar 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 30.30 | 152 | 4,606 | 22,301 | 22.5 K to 22.3 K (-0.68 %) |
| Mar 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 30.30 | 171 | 5,181 | 32,361 | 32.5 K to 32.4 K (-0.53 %) |
| Mar 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Payment of Exercise | F | 30.30 | 177 | 5,363 | 21,062 | 21.2 K to 21.1 K (-0.83 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,000 | 0 | 3,242,014 | 3.2 M to 3.2 M (+0.03 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | VP, Head of Commerc ... | Option Exercise | A | 32.63 | 4,924 | 160,670 | 4,924 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | VP, Head of Commerc ... | Option Exercise | A | 32.63 | 22,576 | 736,655 | 22,576 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | A | 32.63 | 4,189 | 136,687 | 4,189 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | A | 32.63 | 20,811 | 679,063 | 20,811 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 32.63 | 4,411 | 143,931 | 4,411 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 32.63 | 25,589 | 834,969 | 25,589 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 32.63 | 4,751 | 155,025 | 4,751 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 32.63 | 32,749 | 1,068,600 | 32,749 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | A | 32.63 | 4,377 | 142,822 | 4,377 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | A | 32.63 | 95,623 | 3,120,178 | 95,623 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 1,000 | 0 | 6,666 | 5.7 K to 6.7 K (+17.65 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 1,000 | 0 | 113,116 | 112.1 K to 113.1 K (+0.89 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Kress Jean-Paul | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Kress Jean-Paul | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 1,000 | 0 | 113,116 | 112.1 K to 113.1 K (+0.89 %) |
| Jan 24 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Payment of Exercise | F | 32.66 | 4,466 | 145,860 | 71,169 | 75.6 K to 71.2 K (-5.90 %) |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 1,000 | 23,850 | 15,768 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 1,000 | 23,850 | 22,453 | 21.5 K to 22.5 K (+4.66 %) |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | M | 23.85 | 1,000 | 23,850 | 15,768 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Buy | M | 23.85 | 1,000 | 23,850 | 32,532 | 31.5 K to 32.5 K (+3.17 %) |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 26.24 | 1,000 | 26,240 | 12,097 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 26.24 | 1,000 | 26,240 | 21,239 | 20.2 K to 21.2 K (+4.94 %) |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | M | 8.28 | 3,000 | 24,840 | 45,309 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Buy | M | 8.28 | 3,000 | 24,840 | 75,635 | 72.6 K to 75.6 K (+4.13 %) |
| Oct 24 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Payment of Exercise | F | 49.05 | 4,348 | 213,269 | 72,635 | 77 K to 72.6 K (-5.65 %) |
| Oct 19 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | M | 13.90 | 30,000 | 417,000 | 19,874 | |
| Oct 19 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Sell | S | 50.08 | 30,000 | 1,502,502 | 31,532 | 61.5 K to 31.5 K (-48.76 %) |
| Oct 19 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Buy | M | 13.90 | 30,000 | 417,000 | 61,532 | 31.5 K to 61.5 K (+95.14 %) |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.90 | 7,311 | 101,623 | 8,486 | |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 60.00 | 7,311 | 438,660 | 20,239 | 27.6 K to 20.2 K (-26.54 %) |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.90 | 7,311 | 101,623 | 27,550 | 20.2 K to 27.6 K (+36.12 %) |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | M | 13.90 | 40,179 | 558,488 | 40,179 | |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Sell | S | 60.00 | 40,179 | 2,410,740 | 76,983 | 117.2 K to 77 K (-34.29 %) |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Buy | M | 8.28 | 40,179 | 332,682 | 117,162 | 77 K to 117.2 K (+52.19 %) |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.90 | 7,000 | 97,300 | 65,007 | |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 60.00 | 7,000 | 420,000 | 21,453 | 28.5 K to 21.5 K (-24.60 %) |
| Sep 26 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.90 | 7,000 | 97,300 | 28,453 | 21.5 K to 28.5 K (+32.63 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Option Exercise | M | 4.62 | 25,000 | 115,500 | 61,580 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Option Exercise | M | 4.62 | 10,000 | 46,200 | 3,420 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Sell | S | 50.00 | 25,000 | 1,250,000 | 11,490 | 36.5 K to 11.5 K (-68.51 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Buy | M | 4.62 | 25,000 | 115,500 | 36,490 | 11.5 K to 36.5 K (+217.58 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Sell | S | 50.00 | 10,000 | 500,000 | 11,490 | 21.5 K to 11.5 K (-46.53 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | VP, Technical Opera ... | Buy | M | 4.62 | 10,000 | 46,200 | 21,490 | 11.5 K to 21.5 K (+87.03 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | M | 5.40 | 10,405 | 56,187 | 0 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | M | 5.40 | 947 | 5,114 | 0 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Option Exercise | M | 13.90 | 13,000 | 180,700 | 80,358 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Sell | S | 50.00 | 10,405 | 520,250 | 76,983 | 87.4 K to 77 K (-11.91 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Buy | M | 5.40 | 10,405 | 56,187 | 87,388 | 77 K to 87.4 K (+13.52 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Sell | S | 50.00 | 947 | 47,350 | 76,983 | 77.9 K to 77 K (-1.22 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Buy | M | 5.40 | 947 | 5,114 | 77,930 | 77 K to 77.9 K (+1.23 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Sell | S | 50.00 | 13,000 | 650,000 | 76,983 | 90 K to 77 K (-14.45 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | President, CEO & CM ... | Buy | M | 8.28 | 13,000 | 107,640 | 89,983 | 77 K to 90 K (+16.89 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.90 | 8,000 | 111,200 | 72,007 | |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 50.00 | 1,304 | 65,200 | 21,453 | 22.8 K to 21.5 K (-5.73 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Grant | A | 0.00 | 19,125 | 0 | 22,757 | 3.6 K to 22.8 K (+526.57 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Grant | A | 0.00 | 464 | 0 | 3,632 | 3.2 K to 3.6 K (+14.65 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 50.00 | 8,000 | 400,000 | 3,168 | 11.2 K to 3.2 K (-71.63 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.90 | 8,000 | 111,200 | 11,168 | 3.2 K to 11.2 K (+252.53 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Grant | A | 0.00 | 23,906 | 0 | 31,532 | 7.6 K to 31.5 K (+313.48 %) |
| Sep 21 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Grant | A | 0.00 | 524 | 0 | 7,626 | 7.1 K to 7.6 K (+7.38 %) |
| Sep 16 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Sell | S | 30.00 | 24,557 | 736,710 | 76,983 | 101.5 K to 77 K (-24.18 %) |
| Sep 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 26.07 | 1,487 | 38,766 | 101,540 | 103 K to 101.5 K (-1.44 %) |
| Sep 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Payment of Exercise | F | 26.07 | 1,013 | 26,409 | 7,102 | 8.1 K to 7.1 K (-12.48 %) |
| Sep 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Payment of Exercise | F | 26.07 | 765 | 19,944 | 11,490 | 12.3 K to 11.5 K (-6.24 %) |
| Sep 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 26.07 | 898 | 23,411 | 3,168 | 4.1 K to 3.2 K (-22.09 %) |
| Jul 22 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 22.46 | 3,001 | 67,402 | 103,027 | 106 K to 103 K (-2.83 %) |
| Mar 16 2016 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | P | 14.54 | 10,000 | 145,433 | 21,855 | 11.9 K to 21.9 K (+84.35 %) |
| Mar 16 2016 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | P | 16.54 | 65,000 | 1,075,276 | 112,166 | 47.2 K to 112.2 K (+137.81 %) |
| Mar 16 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 15.66 | 75,000 | 1,174,185 | 3,241,014 | 3.2 M to 3.2 M (+2.37 %) |
| Mar 16 2016 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Buy | P | 16.70 | 4,500 | 75,144 | 42,830 | 38.3 K to 42.8 K (+11.74 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.71 | 36,979 | 506,982 | 36,979 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.71 | 521 | 7,143 | 521 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.71 | 33,966 | 465,674 | 33,966 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.71 | 3,534 | 48,451 | 3,534 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Grant | A | 0.00 | 3,115 | 0 | 8,115 | 5 K to 8.1 K (+62.30 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Option Exercise | A | 13.71 | 14,754 | 202,277 | 14,754 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Option Exercise | A | 13.71 | 246 | 3,373 | 246 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Option Exercise | A | 13.71 | 10,625 | 145,669 | 10,625 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Option Exercise | A | 13.71 | 4,375 | 59,981 | 4,375 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP, Technical Oper ... | Grant | A | 0.00 | 2,352 | 0 | 12,255 | 9.9 K to 12.3 K (+23.75 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Grant | A | 0.00 | 1,000 | 0 | 38,330 | 37.3 K to 38.3 K (+2.68 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 1,000 | 0 | 47,166 | 46.2 K to 47.2 K (+2.17 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Grant | A | 0.00 | 1,000 | 0 | 8,166 | 7.2 K to 8.2 K (+13.95 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kress Jean-Paul | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kress Jean-Paul | Director | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 1,000 | 0 | 4,666 | 3.7 K to 4.7 K (+27.28 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,000 | 0 | 3,166,014 | 3.2 M to 3.2 M (+0.03 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Option Exercise | A | 13.71 | 98,611 | 1,351,957 | 98,611 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Option Exercise | A | 13.71 | 1,389 | 19,043 | 1,389 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Option Exercise | A | 13.71 | 95,426 | 1,308,290 | 95,426 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Option Exercise | A | 13.71 | 4,574 | 62,710 | 4,574 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Grant | A | 0.00 | 4,704 | 0 | 109,029 | 113.7 K to 109 K (-4.14 %) |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.71 | 25,090 | 343,984 | 25,090 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.71 | 4,910 | 67,316 | 4,910 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.71 | 29,583 | 405,583 | 29,583 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.71 | 417 | 5,717 | 417 | |
| Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Grant | A | 0.00 | 2,762 | 0 | 4,066 | 1.3 K to 4.1 K (+211.81 %) |
| Apr 22 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 19.71 | 3,001 | 59,150 | 106,028 | 109 K to 106 K (-2.75 %) |
| Jan 25 2016 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 13.26 | 3,368 | 44,660 | 103,525 | 106.9 K to 103.5 K (-3.15 %) |
| Oct 22 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 26.74 | 3,001 | 80,247 | 106,893 | 109.9 K to 106.9 K (-2.73 %) |
| Oct 08 2015 | SRPT | Sarepta Therapeuti ... | Kress Jean-Paul | Director | Option Exercise | A | 31.90 | 7,692 | 245,375 | 7,692 | |
| Jul 31 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Payment of Exercise | F | 33.48 | 3,000 | 100,440 | 109,094 | 112.1 K to 109.1 K (-2.68 %) |
| Jun 04 2015 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 25.18 | 9,746 | 245,404 | 9,746 | |
| Jun 04 2015 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 25.18 | 9,746 | 245,404 | 9,746 | |
| Apr 22 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP Interim CEO & C ... | Grant | A | 0.00 | 110,783 | 0 | 112,094 | 1.3 K to 112.1 K (+8,450.27 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 1,000 | 0 | 4,666 | 3.7 K to 4.7 K (+27.28 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Grant | A | 0.00 | 1,000 | 0 | 37,330 | 36.3 K to 37.3 K (+2.75 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.90 | 119,864 | 1,666,110 | 119,864 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | Senior Vice Preside ... | Option Exercise | A | 13.90 | 6,136 | 85,290 | 6,136 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP & Chief Medical ... | Option Exercise | A | 13.90 | 153,800 | 2,137,820 | 153,800 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP & Chief Medical ... | Option Exercise | A | 13.90 | 9,200 | 127,880 | 9,200 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | SVP & Chief Medical ... | Buy | P | 11.82 | 800 | 9,452 | 1,311 | 511 to 1.3 K (+156.56 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.90 | 76,397 | 1,061,918 | 76,397 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 13.90 | 9,603 | 133,482 | 9,603 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Grant | A | 0.00 | 1,000 | 0 | 6,333 | 5.3 K to 6.3 K (+18.75 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Grant | A | 0.00 | 1,000 | 0 | 7,166 | 6.2 K to 7.2 K (+16.22 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Christopher Nishan Garabedian | President and CEO | Option Exercise | A | 13.90 | 365,804 | 5,084,676 | 365,804 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Christopher Nishan Garabedian | President and CEO | Option Exercise | A | 13.90 | 7,196 | 100,024 | 7,196 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Christopher Nishan Garabedian | President and CEO | Buy | P | 11.82 | 800 | 9,452 | 29,552 | 28.8 K to 29.6 K (+2.78 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Grant | A | 0.00 | 1,000 | 0 | 67,194 | 66.2 K to 67.2 K (+1.51 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 1,000 | 0 | 46,166 | 45.2 K to 46.2 K (+2.21 %) |
| Mar 03 2015 | SRPT | Sarepta Therapeuti ... | Aphale Jayant | SVP Technical Opera ... | Option Exercise | A | 13.90 | 75,392 | 1,047,949 | 75,392 |